The Alzheimer's Association has announced that its Step Up the Pace campaign has raised $109 million since 2014 in support of efforts to accelerate the pace of research on Alzheimer's disease.
Announced at the association's conference in Chicago last week, the total includes gifts ranging from $100,000 to $5 million from nearly a hundred and forty individuals, corporations, and organizations. Funds raised by the campaign have enabled the association to increase its funding commitments to $160 million in support of more than four hundred projects in twenty-one countries, including a clinical trial of an innovative "drug cocktail" to treat Alzheimer's and drug trials focused on the prevention of dementia symptoms before they occur.
The additional funding also has paved the way for the association-led U.S. POINTER study, a two-year clinical trial to evaluate whether lifestyle interventions that simultaneously target multiple risk factors protect cognitive function in older adults at increased risk for cognitive decline.
"The only way we will achieve the national goal of effectively treating and preventing Alzheimer's disease by 2025 is through research, and that is why we have led the charge to increase both public and private funding of Alzheimer's research," said Alzheimer's Association president and CEO Harry Johns. "Research funding is the fuel for discovery and has changed the trajectory of heart disease, HIV, and many cancers, and we are confident that this funding will do the same for Alzheimer's disease. The Alzheimer's Association is leading the way to ensure that the robust research pipeline has the money needed to make critical discoveries that will lead us to fulfill the national goal."